Cannabis Economist Andrew Livingston Discusses Cannabis Rescheduling and the Future of the Industry During Rootwurks Webinar
May 7, 2024
The possibility of cannabis rescheduling has been a bright spot for a cannabis industry that has been roiled by over-saturation, falling prices, and shrinking profit margins in recent years. And while reclassification falls short of actual federal legalization, it should still have a major impact on the economics of the cannabis industry.
In an upcoming Rootwurks webinar on May 8 at 12 p.m. CT, Vicente director of economics and research Andrew Livingston will break down what it will mean for the cannabis industry now that Schedule III reclassification is happening—and what work for legalization remains to be done.
Viewers will gain expert insight on:
- What rescheduling will mean for the taxes cannabis companies pay
- What the different schedule levels mean
- How much more profitable could cannabis companies be if rescheduling happens
- When Schedule III reclassification will go into effect
- How the news of possible reclassification has affected cannabis markets
- Will rescheduling make it easier for companies to secure funding
- Does rescheduling pave the way for legalization
- How rescheduling falls short of full legalization
- And more!
Register here!
About Andrew Livingston
Andrew Livingston is based in Vicente LLP's Denver office, where he serves a unique role as an economist, business analyst, and general cannabis policy wonk. As the firm's director of economics and research, he assists clients with developing and expanding their enterprises across cannabis markets nationally and internationally. A wide variety of marijuana and hemp businesses look to Andrew for help navigating the regulatory intricacies that influence market dynamics, as well as to create sophisticated revenue models and pro forma for investors and to guide strategic decision-making. [See full profile]